IPO (LSE) Archives - 43North

Skip to content

News
Events
Careers

43North Finals

Home
Founders
Investors
- For Investors
- Refer a Startup
Portfolio
Who We Are

News
Events
Careers

43N Finals

Search for:

Home / Portfolio Companies / IPO (LSE)

HemoGenyx London, UK

Breakthrough therapies for the treatment of blood diseases.

Y1 (2015) Life Sciences EXIT

News
Press Room
Events

Company

Contact
FAQ
Careers
Newsletter
Latitude Podcast

Founders

For Founders
Founder Login
About the 43N Program

Investors

For Investors
Join our Investor Network
Our Portfolio

Funding for 43North program activities has been provided in part by Empire State Development.

© 2024 43North

Terms & Conditions